Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Oct 4, 2025 | PRLD | Prelude Therapeutics Inc | FTAX | 3,355 | $1.47 | $4.9K | -3.7% | Open the original filing on SEC.gov |
| Oct 4, 2025 | PRLD | Prelude Therapeutics Inc | MEXER | 9,375 | — | — | +11.6% | Open the original filing on SEC.gov |
| Jul 4, 2025 | PRLD | Prelude Therapeutics Inc | MEXER◆ | 9,375 | — | — | — | Open the original filing on SEC.gov |
| Jul 4, 2025 | PRLD | Prelude Therapeutics Inc | FTAX | 3,355 | $0.7939 | $2.7K | -4.0% | Open the original filing on SEC.gov |
| Jul 4, 2025 | PRLD | Prelude Therapeutics Inc | MEXER | 9,375 | — | — | +12.5% | Open the original filing on SEC.gov |
| Jun 12, 2025 | TARA | Protara Therapeutics, Inc. | AGRANT◆ | 24,000 | — | — | — | Open the original filing on SEC.gov |